logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shoichi Kuyama

iwakuni clinical center
H指数:20
被引数:4,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative Durvalumab for Resectable NSCLC: Updated Outcomes for Japanese Patients in AEGEAN

可切除非小细胞肺癌的围手术期Durvalumab治疗：日本患者AEGEAN研究的更新结果

Cancer Science
IF4.3
2026-09-280
OAAI
Tetsuya Mitsudomi; John V. Heymach; Yoshitsugu Horio; Fumihiro Tanaka; Hiroshi Tanaka; Shoichi Kuyama; Morihito Okada; Shinichi Toyooka; Yasutaka Watanabe; Martin Reck; David Harpole; Janis M. Taube; Yuka Olivo; Huiling Xiong; Tamer M. Fouad; Allen Chen; Hiroaki Akamatsu
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion)

拉姆昔替尼联合厄洛替尼治疗EGFR突变非鳞非小细胞肺癌初治患者伴胸腔积液患者的II期研究（RELAY-Effusion）

Lung Cancer
IF4.4
2026-05-030
OAAI
Hiroyasu Kaneda; Motoko Tachihara; Yukihiro Toi; Shoichi Kuyama; Eiki Ichihara; Yasuhito Fujisaka; Koichi Azuma; Takayasu Kurata; Akihito Kubo; Hisashi Tanaka; Tadaaki Yamada; Toshihide Yokoyama; Takahide Kato; Ken Yamamoto; Nobuyuki Katakami; Ryota Kawai; Hisako Yoshida; Ayumi Shintani; Kenji Sawa; Tomoya Kawaguchi
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

非小细胞肺癌早期阿来替尼耐药的临床特征及空间转录组学分析：一项回顾性OLCSG研究

Cancer Research Communications
IF0
2026-02-011
PRE
Kuribayashi, Tadahiro; Makimoto, Go; Ohashi, Kadoaki; Tomida, Shuta; Inoue, Hirofumi; Yokoyama, Toshihide; Kuyama, Shoichi; Kato, Yuka; Kudo, Kenichiro; Horita, Naokatsu; Kayatani, Hiroe; Inoue, Masaaki; Sugimoto, Keisuke; Ninomiya, Kiichiro; Maeda, Yoshinobu; Togashi, Yosuke; Hotta, Katsuyuki
Atezolizumab plus Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2)

阿特珠单抗联合化疗治疗日本临床实践中晚期非小细胞肺癌（J-TAIL-2）

CANCER SCIENCE
IF4.3
2025-12-010
OAAI
Yoshioka, Hiroshige; Nishio, Makoto; Ohashi, Kadoaki; Osoegawa, Atsushi; Kikuchi, Eiki; Kimura, Hideharu; Goto, Yasushi; Shimizu, Junichi; Miyauchi, Eisaku; Yoshino, Ichiro; Misumi, Toshihiro; Watanabe, Yasutaka; Hata, Akito; Kisohara, Akira; Kuyama, Shoichi; Yamaguchi, Masafumi; Miwa, Asako; Iwasawa, Shunichiro; Tanaka, Misa; Gemma, Akihiko
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non-small cell lung cancer

非小细胞肺癌免疫检查点抑制剂疗效的营养与免疫预测因子的前瞻性验证研究

International Journal of Cancer
IF4.7
2025-10-260
PRE
Shinkichi Takamori; Mototsugu Shimokawa; Masafumi Yamaguchi; Masahide Mori; Shoichi Kuyama; Masahide Oki; Yoshifumi Nishimura; Katsumi Nakatomi; Hidetoshi Yanai; Noriaki Sukoh; Nobuo Hatakeyama; Toshiyuki Kita; Keiichi Fujiwara; Kenji Chibana; Masaki Okamoto; Mitsuhiro Takenoyama
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002)

阿特珠单抗联合卡铂加白蛋白结合型紫杉醇组合疗法治疗肾功能受损的晚期非鳞状非小细胞肺癌：一项多中心、单臂II期试验（RESTART，LOGiK 2002）

LUNG CANCER
IF4.4
2025-05-010
OAAI
Shiraishi, Yoshimasa; Shimose, Takayuki; Tobino, Kazunori; Toi, Yukihiro; Wakuda, Kazushige; Matsumoto, Hirotaka; Sakaguchi, Tadashi; Mashimoto, Ayano; Hayashi, Hidetoshi; Ebina-Shibuya, Risa; Mori, Masahide; Taniguchi, Yuri; Kuyama, Shoichi; Kashiwabara, Kosuke; Furuyama, Kazuto; Yoshimine, Kohei; Kimura, Yuichiro; Kobayashi, Haruki; Kishimoto, Junji; Okamoto, Isamu
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study

30天内出现皮肤疾病是接受尼妥珠单抗联合吉西他滨和顺铂治疗的肺鳞状细胞癌患者的有利预后因素：NINJA研究的亚组分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-03-150
OA
Fumihiko Kinoshita; Shigeru Tanzawa; Toshihiro Misumi; Hiroshige Yoshioka; Eisaku Miyauchi; Kiichiro Ninomiya; Yasunori Murata; Masafumi Takeshita; Masafumi Yamaguchi; Shunichi Sugawara; Yosuke Kawashima; Kazuki Hashimoto; Masahide Mori; Akihiko Miyanaga; Anna Hayashi; Hisashi Tanaka; Ryoichi Honda; Masafumi Nojiri; Yuki Sato; Ken Yamamoto; Ken Masuda; Toshiyuki Kozuki; Takahisa Kawamura; Takuji Suzuki; Teppei Yamaguchi; Kazuhiro Asada; Satoshi Tetsumoto; Hiroshi Tanaka; Satoshi Watanabe; Yukihiro Umeda; Kakuhiro Yamaguchi; Shoichi Kuyama; Kosuke Tsuruno; Yuki Misumi; Hiroshi Kuraishi; Ken Yoshihara; Akira Nakao; Akihito Kubo; Toshihiko Yokoyama; Kana Watanabe; Nobuhiko Seki
First-line (1L) osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) for EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC): FLAURA2 Asian cohort

一线（1L）奥希替尼（osi）± 铂类培美曲塞化疗（CTx）用于EGFR突变（EGFRm）晚期非小细胞肺癌（NSCLC）：FLAURA2亚洲队列

ANNALS OF ONCOLOGY
IF65.4
2024-12-011
PRE
Yang, J. C-H.; Kobayashi, K.; Chewaskulyong, B.; Tran, T. V.; Biswas, B.; Lee, K. H.; Feng, P-H.; Pham, X. D.; Yao, Y.; Kuyama, S.; Bing, J. Y. Tan Chun; Bhise, R.; Ahn, M-J.; Sriuranpong, V.; Li, R. K.; Monterroso, E. Armenteros; Barrett, K.; Albayaty, M.; Cheng, Y.
The Clinical Significance of Interstitial Pneumonia with Autoimmune Features in Cryptogenic Organizing Pneumonia: A Prospective Multicenter Observational Study
JOURNAL OF CLINICAL MEDICINE
IF2.9
2024-11-150
OAAI
Higo, Hisao; Ichikawa, Hirohisa; Arakawa, Yukako; Mori, Yoshihiro; Tamura, Tomoki; Kuyama, Shoichi; Matsumoto, Chiaki; Sugimoto, Keisuke; Hamada, Noboru; Suwaki, Toshimitsu; Itano, Junko; Tanimoto, Yasushi; Senoo, Satoru; Taniguchi, Akihiko; Inukai, Yumi; Arita, Machiko; Makimoto, Satoko; Kojima, Katsuhide; Matsushita, Takashi; Maeda, Yoshinobu; Miyahara, Nobuaki
TROPION-Lung07: Phase III study of Dato-DXd plus pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer

TROPION-Lung07: dato-dxd联合pembrolizumab ± 铂类化疗作为1L治疗晚期非小细胞肺癌的III期研究

FUTURE ONCOLOGY
IF2.6
2024-10-291
OAAI
Okamoto, Isamu; Kuyama, Shoichi; Girard, Nicolas; Lu, Shun; Franke, Fabio; Li, Ziming; Danchaivijitr, Pongwut; Han, Ji-Youn; Sun, Jong-Mu; Sugawara, Shunichi; Pan, Edward; Ren, Natalie; Chen, Aiying; Rajagopalan, Rachana; Lisberg, Aaron E.
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-12-014
OA
Murata, Yasunori; Tanzawa, Shigeru; Misumi, Toshihiro; Yoshioka, Hiroshige; Miyauchi, Eisaku; Ninomiya, Kiichiro; Takeshita, Masafumi; Ito, Kensaku; Okamoto, Tatsuro; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Hata, Akito; Masuda, Ken; Kozuki, Toshiyuki; Kawamura, Takahisa; Suzuki, Takuji; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Kuyama, Shoichi; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-05-012
OA
Goto, Yasushi; Kenmotsu, Hirotsugu; Tamiya, Motohiro; Murakami, Shuji; Kurata, Takayasu; Yanagitani, Noriko; Taniguchi, Hirokazu; Kuyama, Shoichi; Shimizu, Junichi; Yokoyama, Toshihide; Shimada, Naoko; Maeda, Tadashi; Tamiya, Akihiro; Uchiyama, Ayumi; Imaizumi, Kazuyoshi; Takahama, Takayuki; Kato, Terufumi; Hayashi, Hidetoshi; Shiraiwa, Naoko; Toyoizumi, Shigeyuki; Kikkawa, Hironori; Thomaidou, Despina; Nishio, Makoto
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-12-183
OAAI
Tanaka, Hisashi; Tanzawa, Shigeru; Misumi, Toshihiro; Makiguchi, Tomonori; Inaba, Megumi; Honda, Takeshi; Nakamura, Junya; Inoue, Koji; Kishikawa, Takayuki; Nakashima, Masanao; Fujiwara, Keiichi; Kohyama, Tadashi; Ishida, Hiroo; Kuyama, Shoichi; Miyazawa, Naoki; Nakamura, Tomomi; Miyawaki, Hiroshi; Oda, Naohiro; Ishikawa, Nobuhisa; Morinaga, Ryotaro; Kusaka, Kei; Fujimoto, Nobukazu; Fukuda, Yasushi; Yasugi, Masayuki; Tsuda, Takeshi; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Shiraishi, Kenshiro; Matsutani, Noriyuki; Seki, Nobuhiko
A real-world multi-center prospective observational study of atezolizumab (Atezo) plus bevacizumab (Bev) plus carboplatin (CBDCA) plus paclitaxel (PTX) (ABCP) in patients (pts) with advanced EGFR-mutated (EGFRm) NSCLC after EGFR- TKIs failure
ANNALS OF ONCOLOGY
IF65.4
2022-11-010
OAAI
Kuyama, S.; Yoshioka, H.; Kaneda, H.; Kataoka, Y.; Miura, S.; Katakami, N.; Yamanaka, Y.; Tamiya, A.; Yamada, T.; Yokoyama, T.; Hara, S.; Tanaka, H.; Fujisaka, Y.; Nakamura, A.; Azuma, K.; Namba, M.; Hata, A.; Sawa, K.; Ishikawa, H.; Kurata, T.
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-07-291
OAAI
Tanzawa, Shigeru; Makiguchi, Tomonori; Tasaka, Sadatomo; Inaba, Megumi; Ochiai, Ryosuke; Nakamura, Junya; Inoue, Koji; Kishikawa, Takayuki; Nakashima, Masanao; Fujiwara, Keiichi; Kohyama, Tadashi; Ishida, Hiroo; Kuyama, Shoichi; Miyazawa, Naoki; Nakamura, Tomomi; Miyawaki, Hiroshi; Oda, Naohiro; Ishikawa, Nobuhisa; Morinaga, Ryotaro; Kusaka, Kei; Miyamoto, Yosuke; Yokoyama, Toshihide; Matsumoto, Chiaki; Tsuda, Takeshi; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Misumi, Toshihiro; Shiraishi, Kenshiro; Matsutani, Noriyuki; Seki, Nobuhiko
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)

晚期肺癌患者静脉血栓栓塞发生率及直接口服抗凝剂的疗效和安全性: 一项多中心、前瞻性、观察性研究 (Rising-VTE/NEJ037研究)

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-07-2111
OAAI
Tsubata, Yukari; Hotta, Takamasa; Hamai, Kosuke; Furuya, Naoki; Yokoyama, Toshihide; Saito, Ryota; Nakamura, Atsushi; Masuda, Takeshi; Hamaguchi, Megumi; Kuyama, Shoichi; Honda, Ryoichi; Senoo, Tadashi; Nakanishi, Masamoto; Yamasaki, Masahiro; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Kubota, Tetsuya; Ohtsu, Hiroshi; Kobayashi, Kunihiko; Isobe, Takeshi
A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study
JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2022-04-0415
OAAI
Tsubata, Yukari; Hotta, Takamasa; Hamai, Kosuke; Furuya, Naoki; Yokoyama, Toshihide; Saito, Ryota; Nakamura, Atsushi; Masuda, Takeshi; Hamaguchi, Megumi; Kuyama, Shoichi; Honda, Ryoichi; Senoo, Tadashi; Nakanishi, Masamoto; Yamasaki, Masahiro; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Kubota, Tetsuya; Kobayashi, Kunihiko; Isobe, Takeshi

研究方向

暂未获取到该数据
T
Toshihide Yokoyama
H 指数:26论文数:242被引数:5,944
K
Katsuyuki Hotta
H 指数:52论文数:649被引数:3.1万
T
Toshihiro Misumi
H 指数:20论文数:323被引数:2,466
N
Nobuhisa Ishikawa
H 指数:43论文数:285被引数:6,929
K
Kiichiro Ninomiya
H 指数:21论文数:203被引数:1,698
T
Takuo Shibayama
H 指数:21论文数:227被引数:2,061
S
Shigeru Tanzawa
H 指数:9论文数:48被引数:210
H
Hisashi Tanaka
H 指数:19论文数:167被引数:1,125
A
Akihiro Bessho
H 指数:24论文数:215被引数:2,013
N
Naohiro Oda
H 指数:16论文数:120被引数:876